LSBCF (LakeShore Biopharma Co) Current Accrued Expense: $28.29 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is LakeShore Biopharma Co Current Accrued Expense?

LakeShore Biopharma Co LSBCF Current Accrued Expense is $28.29 Mil as of Mar. 2025.

LakeShore Biopharma Co's Current Accrued Expense for the quarter that ended in Mar. 2025 was $28.29 Mil.

LakeShore Biopharma Co's quarterly Current Accrued Expense increased from Mar. 2024 ($27.21 Mil) to Sep. 2024 ($55.39 Mil) but then declined from Sep. 2024 ($55.39 Mil) to Mar. 2025 ($28.29 Mil).

LakeShore Biopharma Co's annual Current Accrued Expense increased from Mar. 2023 ($23.02 Mil) to Mar. 2024 ($27.21 Mil) and increased from Mar. 2024 ($27.21 Mil) to Mar. 2025 ($28.29 Mil).

LakeShore Biopharma Co Current Accrued Expense Related Terms

LakeShore Biopharma Co Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Current Accrued Expense Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Current Accrued Expense
26.58 18.47 23.02 27.21 28.29

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only 23.02 53.18 27.21 55.39 28.29

LakeShore Biopharma Co Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $28.29 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Current Accrued Expense of $28.29 Mil as of Mar. 2025. Current Accrued Expense records the total amount of accrued expenses. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Current Accrued Expense too high?
LakeShore Biopharma Co's current Current Accrued Expense is $28.29 Mil.
How does LakeShore Biopharma Co's Current Accrued Expense compare to ACUT and PPCB?
LakeShore Biopharma Co's Current Accrued Expense of $28.29 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Biotechnology company?
A good Current Accrued Expense depends on the Biotechnology industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Current Accrued Expense is $28.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Current Accrued Expense of $28.29 Mil. The current Current Accrued Expense is $28.29 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Current Accrued Expense is $28.29 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.